These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23486520)

  • 1. Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patients.
    Ou SM; Chen YT; Chao PW; Lee YJ; Liu CJ; Yeh CM; Chen TJ; Chen TW; Yang WC; Li SY
    Kidney Int; 2013 Jul; 84(1):198-205. PubMed ID: 23486520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
    Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
    Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects With Hypertension: Nationwide Longitudinal Cohort Study.
    Hsu CC; Wang H; Hsu YH; Chuang SY; Huang YW; Chang YK; Liu JS; Hsiung CA; Tsai HJ
    Hypertension; 2015 Sep; 66(3):524-33. PubMed ID: 26169048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroidal antiinflammatory drugs and risk of gastrointestinal bleeding among patients on hemodialysis.
    Jankovic SM; Aleksic J; Rakovic S; Aleksic A; Stevanovic I; Stefanovic-Stoimenov N; Radosavljevic M; Kostic M; Tesic D; Petrovic B
    J Nephrol; 2009; 22(4):502-7. PubMed ID: 19662606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study.
    Chang YK; Liu JS; Hsu YH; Tarng DC; Hsu CC
    Medicine (Baltimore); 2015 Sep; 94(38):e1362. PubMed ID: 26402800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of hospitalization for upper gastrointestinal adverse events associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study in Taiwan.
    Chang CH; Chen HC; Lin JW; Kuo CW; Shau WY; Lai MS
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):763-71. PubMed ID: 21618340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.
    Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A
    Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin.
    Cheetham TC; Levy G; Niu F; Bixler F
    Ann Pharmacother; 2009 Nov; 43(11):1765-73. PubMed ID: 19809010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal antiinflammatory drug use and cardiovascular risks after coronary stent implantation.
    Schmidt M; Pedersen L; Maeng M; Lassen JF; Lash TL; Nielsen TT; Sørensen HT
    Pharmacotherapy; 2011 May; 31(5):458-68. PubMed ID: 21923427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer.
    Rahme E; Ghosn J; Dasgupta K; Rajan R; Hudson M
    BMC Cancer; 2005 Dec; 5():159. PubMed ID: 16343343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study.
    Schjerning Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Lamberts M; Bjerring Olesen J; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
    Circulation; 2011 May; 123(20):2226-35. PubMed ID: 21555710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAID use and progression of chronic kidney disease.
    Gooch K; Culleton BF; Manns BJ; Zhang J; Alfonso H; Tonelli M; Frank C; Klarenbach S; Hemmelgarn BR
    Am J Med; 2007 Mar; 120(3):280.e1-7. PubMed ID: 17349452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of nonsteroidal anti-inflammatory drugs prior to chronic renal replacement therapy initiation: a nationwide study.
    Kristensen SL; Fosbøl EL; Kamper AL; Køber L; Hommel K; Lamberts M; Abildstrøm SZ; Blicher TM; Torp-Pedersen C; Gislason GH
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):428-34. PubMed ID: 22344680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.
    Lanas Á; Carrera-Lasfuentes P; Arguedas Y; García S; Bujanda L; Calvet X; Ponce J; Perez-Aísa Á; Castro M; Muñoz M; Sostres C; García-Rodríguez LA
    Clin Gastroenterol Hepatol; 2015 May; 13(5):906-12.e2. PubMed ID: 25460554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenteric ischemia in patients with end-stage renal disease: a nationwide longitudinal study.
    Li SY; Chen YT; Chen TJ; Tsai LW; Yang WC; Chen TW
    Am J Nephrol; 2012; 35(6):491-7. PubMed ID: 22572613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study.
    Peng YL; Hu HY; Luo JC; Hou MC; Lin HC; Lee FY
    Osteoporos Int; 2014 May; 25(5):1617-23. PubMed ID: 24566586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study.
    Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Bjerring Olesen J; Lamberts M; Ruwald MH; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
    Circulation; 2012 Oct; 126(16):1955-63. PubMed ID: 22965337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
    Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C
    Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
    Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
    Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study.
    Etminan M; Lévesque L; Fitzgerald JM; Brophy JM
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1188-92. PubMed ID: 19298582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.